Phase 2 Clinical Testing

Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity

Copenhagen, Denmark & Ingelheim, Germany:  New studies mark an important advancement of Boehringer Ingelheim’s cardiometabolic focus areas obesity and NASH.…

Read More »